Zahn; Stephan Karl
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zahn; Stephan Karl.The latest application filed is for "tosylacetate based compounds and derivatives thereof as phgdh inhibitors".
- Zahn; Stephan Karl - Vienna AT
| Patent | Date |
|---|---|
| Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors Grant 11,304,929 - Weinstabl , et al. April 19, 2 | 2022-04-19 |
| Tosylacetate Based Compounds And Derivatives Thereof As Phgdh Inhibitors App 20220008386 - WEINSTABL; Harald ; et al. | 2022-01-13 |
| 5,8-dimethyl-9-phenyl-5,8-dihydro-6H-pyrazolo[3,4-h]quinazolin-2-yl)-(1H-p- yrazol-3-yl)-amines as IGF-1R/IR inhibitors Grant 10,414,769 - Treu , et al. Sept | 2019-09-17 |
| New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2-yl)-(- 1h-pyrazol-3-yl)-amines And Derivatives As Igf-1r/ir Inhibitors App 20180141948 - TREU; Matthias ; et al. | 2018-05-24 |
| Anticancer compounds Grant 8,937,095 - Zahn , et al. January 20, 2 | 2015-01-20 |
| Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors Grant 8,653,087 - Mantoulidis , et al. February 18, 2 | 2014-02-18 |
| Crystalline Form Of A Indolinone Derivative And Its Use App 20140018372 - MAIER; Gerd-Michael ; et al. | 2014-01-16 |
| Anticancer Compounds App 20140018405 - ZAHN; Stephan Karl ; et al. | 2014-01-16 |
| Compounds Grant 8,623,887 - Zahn , et al. January 7, 2 | 2014-01-07 |
| 2,4-diamino-pyrimidines As Aurora Inhibitors App 20130281429 - ZAHN; Stephan Karl ; et al. | 2013-10-24 |
| Benzylic oxindole pyrimidines Grant 8,546,443 - Treu , et al. October 1, 2 | 2013-10-01 |
| Benzylic Oxindole Pyrimidines App 20120329771 - TREU; Matthias ; et al. | 2012-12-27 |
| Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer App 20120270859 - TREU; Matthias ; et al. | 2012-10-25 |
| Substituted indolines as tyrosine kinase inhibitors Grant 8,207,179 - Engelhardt , et al. June 26, 2 | 2012-06-26 |
| Pyrido [5, 4-d] Pyrimidines As Cell Proliferation Inhibitors App 20120094975 - Mantoulidis; Andreas ; et al. | 2012-04-19 |
| 2,4-diamino-pyrimidines As Aurora Inhibitors App 20110251174 - ZAHN; Stephan Karl ; et al. | 2011-10-13 |
| Pyrimidines as PLK inhibitors App 20110086842 - STADTMUELLER; Heinz ; et al. | 2011-04-14 |
| New Compounds App 20100222331 - Engelhardt; Harald ; et al. | 2010-09-02 |
| Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer App 20100184747 - Treu; Matthias ; et al. | 2010-07-22 |
| Compounds App 20100144706 - Zahn; Stephan Karl ; et al. | 2010-06-10 |
| 2,4-diaminopyrimidines useful for treating cell proliferation diseases Grant 7,569,561 - Stadtmueller , et al. August 4, 2 | 2009-08-04 |
| New compounds App 20090163467 - Zahn; Stephan Karl ; et al. | 2009-06-25 |
| Pyrimidines as PLK inhibitors App 20090163465 - STADTMUELLER; Heinz ; et al. | 2009-06-25 |
| Pyrimidines as PLK inhibitors App 20090149438 - STADTMUELLER; Heinz ; et al. | 2009-06-11 |
| Pyrimidines as PLK inhibitors Grant 7,521,457 - Stadtmueller , et al. April 21, 2 | 2009-04-21 |
| New Compounds App 20070207999 - Stadtmueller; Heinz ; et al. | 2007-09-06 |
| Pyrimidines as PLK inhibitors Grant 7,241,769 - Stadtmueller , et al. July 10, 2 | 2007-07-10 |
| 2,4-diamino-pyrimidines as aurora inhibitors App 20070032514 - Zahn; Stephan Karl ; et al. | 2007-02-08 |
| Pyrimidines as PLK inhibitors App 20060148800 - Stadtmueller; Heinz ; et al. | 2006-07-06 |
| Pyrimidine as PLK inhibitors App 20050261295 - Stadtmueller, Heinz ; et al. | 2005-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 